268600.KQ

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Biotechnology

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
268600.KQCellivery Therapeutics, Inc.	$6680.00	+0.00%	$248.4B	—
002210.KSDong Sung Bio Pharm.Co.,Ltd.	$1368.00	+1.33%	$33.4B	—
007575.KSIlyang Pharmaceutical Co.,Ltd	$7430.00	+0.00%	$151.7B	—
023910.KSDaihan Pharmaceutical Co.	$25800.00	-1.15%	$151.7B	—
182400.KQNKMAX Co. Ltd.	$2020.00	+0.00%	$172.7B	—
241820.KQPCL, Inc.	$302.00	-1.63%	$15.5B	—
294090.KQEOFLOW Co.,Ltd.	$1490.00	-5.64%	$50.8B	—

Source: Financial Modeling Prep · peers by sector/industry

Cellivery Therapeutics, Inc.

Cellivery Therapeutics, Inc. is dedicated to pioneering therapeutic drugs designed to combat critical and often fatal conditions, including various cancers, inflammatory disorders, metabolic diseases, and neurodegenerative ailments. The company leverages its proprietary Therapeutic molecule Systemic Delivery Technology to develop a diverse pipeline of small molecule compounds, antibodies, and vaccines. Established in 2014, this firm is headquartered in Seoul, South Korea.

www.cellivery.com

Employees: 22
IPO / List date: Nov 9, 2018
HQ: KR

Held by traders on TradeandTell

No one on the platform currently holds 268600.KQ.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in 268600.KQ as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded 268600.KQ yet.